Back to Search
Start Over
Blood pressure reduction does not reduce perihematoma oxygenation: a CT perfusion study.
- Source :
-
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism [J Cereb Blood Flow Metab] 2014 Jan; Vol. 34 (1), pp. 81-6. Date of Electronic Publication: 2013 Sep 18. - Publication Year :
- 2014
-
Abstract
- Blood pressure (BP) reduction after intracerebral hemorrhage (ICH) is controversial, because of concerns that this may cause critical reductions in perihematoma perfusion and thereby precipitate tissue damage. We tested the hypothesis that BP reduction reduces perihematoma tissue oxygenation.Acute ICH patients were randomized to a systolic BP target of <150 or <180 mm Hg. Patients underwent CT perfusion (CTP) imaging 2 hours after randomization. Maps of cerebral blood flow (CBF), maximum oxygen extraction fraction (OEF(max)), and the resulting maximum cerebral metabolic rate of oxygen (CMRO2(max)) permitted by local hemodynamics, were calculated from raw CTP data.Sixty-five patients (median (interquartile range) age 70 (20)) were imaged at a median (interquartile range) time from onset to CTP of 9.8 (13.6) hours. Mean OEF(max) was elevated in the perihematoma region (0.44±0.12) relative to contralateral tissue (0.36±0.11; P<0.001). Perihematoma CMRO2(max) (3.40±1.67 mL/100 g per minute) was slightly lower relative to contralateral tissue (3.63±1.66 mL/100 g per minute; P=0.025). Despite a significant difference in systolic BP between the aggressive (140.5±18.7 mm Hg) and conservative (163.0±10.6 mm Hg; P<0.001) treatment groups, perihematoma CBF was unaffected (37.2±11.9 versus 35.8±9.6 mL/100 g per minute; P=0.307). Similarly, aggressive BP treatment did not affect perihematoma OEF(max) (0.43±0.12 versus 0.45±0.11; P=0.232) or CMRO2(max) (3.16±1.66 versus 3.68±1.85 mL/100 g per minute; P=0.857). Blood pressure reduction does not affect perihematoma oxygen delivery. These data support the safety of early aggressive BP treatment in ICH.
- Subjects :
- Aged
Antihypertensive Agents administration & dosage
Cerebral Hemorrhage complications
Cerebral Hemorrhage diagnostic imaging
Cerebral Hemorrhage physiopathology
Female
Hematoma diagnostic imaging
Hematoma drug therapy
Hematoma etiology
Humans
Hydralazine administration & dosage
Hydralazine therapeutic use
Labetalol administration & dosage
Labetalol therapeutic use
Male
Treatment Outcome
Antihypertensive Agents therapeutic use
Blood Pressure drug effects
Cerebral Hemorrhage drug therapy
Hematoma metabolism
Oxygen Consumption drug effects
Tomography, X-Ray Computed methods
Subjects
Details
- Language :
- English
- ISSN :
- 1559-7016
- Volume :
- 34
- Issue :
- 1
- Database :
- MEDLINE
- Journal :
- Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism
- Publication Type :
- Academic Journal
- Accession number :
- 24045403
- Full Text :
- https://doi.org/10.1038/jcbfm.2013.164